Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation

Clinical Transplantation, Supplement

Volumn 19, Issue 14, 2005, Pages 41-48

  Moriyama, Takahito ^a   Nitta, Kosaku ^a   Suzuki, Koichi ^a   Honda, Kazuho ^a   Horita, Shigeru ^a   Uchida, Keiko ^a   Yumura, Wako ^a   Tanabe, Kazunari ^a   Toma, Hiroshi ^a   Nihei, Hiroshi ^a   Yamaguchi, Yutaka ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IgA deposition; Recurrent IgA nephropathy; Renal transplantation

Indexed keywords

CREATININE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN A;

ADULT; AGE; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GENDER; HEMATURIA; HEMODIALYSIS; HLA MATCHING; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; JAPAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RECURRENT DISEASE; RISK FACTOR; URINARY EXCRETION;

EID: 22244465886     PISSN: 13996738     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00403.x     Document Type: Article

References (26)

1. Berger J, Hinglais N. Les deposits intercapillarired'IgA-IgG. J Urol Nephrol 1968: 74: 694.
2. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kid Dis 2000: 36: 227.
3. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003: 18: 2399.
4. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 2001: 56: 279.
5. Koselj-Kajtna M, Kandus A, Koselj M et al. Outcome of renal transplants in patients with IgA Nephropathy. Transplant Pro 2001: 33: 3249.
6. Ohmacht C, Kliem V, Burg M et al. Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. Transplant 1997: 64: 1493.
7. Park SB, Kim HC, Kim HT et al. Long-term outcome of IgA nephropathy in living related kidney transplantation. Transplant Pro 2000: 32: 1828.
8. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1998: 12: 371.
9. Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994: 9: 309.
10. Hartung R, Livingston B, Excell L et al. Recurrence of IgA deposits/disease in grafts: Contrib Nephrol 1995: 111: 13.
11. Sumethkul V, Jirasirtham S, Chalermsanyakorn P, Buranachokpaisan W. Chronic rejection: a significant predictor of poor outcome for recurrence IgA nephropathy. Transplant Pro 2001: 33: 3375.
12. Floege J, Burg M, Kleim V. Recurrent IgA nephropathy after kidney transplantation: not a benign condition. Nephrol Dial Transplant 1998: 13: 1933.
13. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplant 1998: 65: 1053.
14. Frohnert PP, Donaldio JV Jr, Velosa JA et al. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 1997: 11: 127.
15. Freese P, Svalander C, Norden G, Nyberg G. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999: 13: 313.
16. Ponticelli C, Traversi L, Feliciani A et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001: 60: 1948.
17. Koselj M, Rott T, Vizjak A, Kveder R. IgA nephropathy as a donor-transmitted disease in renal transplant recipients. Transplant Proc 1991: 23: 2634.
18. Morozumi K, Suganuma T, Yoshida A et al. Studies of post-transplant glomerulonephritis in patients immuno-suppressed with cyclosporine A. Transplant Proc 1987: 19: 3703.
19. Suganuma T, Morozumi K, Satoh K et al. Studies of IgA nephropathy in renal transplantation. Transplant Proc 1989: 21: 2123.
20. Silva FG, Chander P, Pirani CL, Hardy MA. Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplant 1982: 33: 241.
21. Koselj M, Rott T, Kandus A et al. Donor-transmitted IgA nephropathy: long-term follow-up of kidney donors and recipients. Transplant Proc 1997: 29: 3406.
22. Sanfilippo F, Croker BP, Bollinger RR. Fate of four cadaveric doner renal allografts with mesangial IgA deposits. Transplant 1982: 33: 370.
23. Suzuki K, Konda K, Tanabe K et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003: 63: 2286.
24. Racusen LC, Solez K, Colvin RB et al. The Banff working classification of kidney transplant pathology. Kidney Int 1999: 55: 713.
25. Wang AY, Lai FM, Yu AW et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001: 38: 588.
26. Stack A, Campbell E, Browne O et al. Previous and predictors of recurrent IgA nephropathy following renal transplantation. Irish J Med Science 1997: 169: 248.